<unk>  (Ad5/3-D24-GMCSF), (developed by<unk>  Therapeutics) is an<unk> ytic adenovirus previously described as CGTG-102. It is currently in orphan drug status for soft tissue sarcomas.
ONCOS-102
CARB-X
MCN
SCALPEL
BGR-34
BIM-1
COVAX-19
CURB-65